Total investments received (USD): 2.29m
Round value (USD): 2.29m
Round investors:
Capital Cell
Company: Immuni Therapeutics
Industry:
Biotech
Health services

Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
United Kingdom